Navigation Links
Yongye Biotechnology International Raises $ 9.0 Million In Private Placement, Raises Guidance
Date:5/8/2009

and drive expansion of the distribution network. We can now measure the successful results of this strategy through the increased number of orders we received. The funds from this new private placement will help us fill the orders we received for our upcoming busy season, the second and third quarters of the year," said Mr. Zishen Wu, CEO of Yongye Biotechnology International, Inc.

The securities issued in the private placement are not registered under the United States Securities Act of 1933 or the securities laws of any other jurisdiction. Accordingly, these securities may not be sold by investors in the United States, except pursuant to an effective registration statement or an applicable exemption from the registration requirements. For more detailed information on this financing, see the Company's Current Report on Form 8-K which will be filed with the Securities and Exchange Commission on or about May 8, 2009.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any security and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About Yongye Biotechnology International, Inc.

Yongye Biotechnology International, Inc., headquartered in Beijing, is engaged in the development and distribution of fulvic acid based nutrients for plants and animals. The Company's patent pending processes and proprietary formulas allow it to create products which increase crop yields and improve the health of livestock. Its sole operating subsidiary, Yongye Nongfeng Biotechnology Company, Ltd., is located in Inner Mongolia. The Company sells its products through distributors and directly to farmers located in ten provinces throughout China.

Forward Looking Statements

Certain statements set forth in this press release constitute "Forward- looking statement
'/>"/>

SOURCE Yongye Biotechnology International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Yongye Biotechnology Distributor has Record Breaking Single Store Sales Day
2. Yongye Biotechnology Announces Preliminary Results for its Fiscal Quarter Ended March 31, 2009
3. Yongye Biotechnology Appoints New Chief Financial Officer
4. Yongye Biotechnology Announces Preliminary Results for Fiscal Year 2008
5. Yongye Biotechnology to Host Virtual Retail Road Show to Provide Overview of the Company in English and Mandarin
6. Yongye Biotechnology International to Expand its Network of Branded Stores
7. Yongye Biotechnology to Present at Roth Conference
8. Yongye Biotechnology Announces Record Third Quarter Results
9. Yongye Biotechnology to Present at Roth Capital China Comes to Vegas Conference
10. Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
11. Yongye Biotechnology International Raises $9.4 Million in Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Through rare discovery of new physics and ... is enabling World Scientists to actually see, watch, and ... the full nature (position, shape, size, number) of molecules, ... Co-Founder of the Yancy Corporation, says, "Our rare discoveries ... come once in a lifetime, if at all. Our ...
(Date:6/2/2015)... GenoCAD , a platform leveraging ... expression, announced the formation of its new board of ... with a broad range of experience in the biotechnology, ... includes: , Jimmy Roussel, Entrepreneur in Residence at The ... in technology and marketing. He has served in operations ...
(Date:6/1/2015)... 2015 Research and ... addition of the "Oxidative Stress Assay ... Type (Indirect, Enzyme-based, Reactive Oxygen Species (ROS)-based), ... - Global Forecast to 2020" report ... http://photos.prnewswire.com/prnh/20130307/600769) , The global oxidative ...
(Date:6/1/2015)... , June 1, 2015 GenomeDx ... genomic analysis platform, successfully classified various subtypes ... expression of certain biomarkers, including one type ... this unique genomic signature has potential as ... neoadjuvant chemotherapy in patients with muscle-invasive bladder ...
Breaking Biology Technology:Scientists Eying Rare Discovery Of New Physics & Light Microscope Technology 2GenoCAD Announces New Board of Advisors, Improves Protein Expression Using Custom Gene Synthesis 2GenoCAD Announces New Board of Advisors, Improves Protein Expression Using Custom Gene Synthesis 3Oxidative Stress Assay Market 2015 - Global Forecast to 2020 2GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 2GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 3GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 4
... Nov. 21 Gen-Probe,s (Nasdaq: GPRO ... new molecular tool to more,accurately detect high-risk human ... or precancerous lesions, according to nine,oral presentations and ... Gen-Probe researchers at the international conference of the,European ...
... of NC,s biotechnology sector is $45.8 billion, 180,007 jobs , ... Nov. 20 North Carolina has invested more than $1 ... years, and the annual economic impact exceeds $45 billion, according ... , , Norris Tolson, president ...
... Discovery Channel, will showcase the cutting edge technology and on-site laboratories ... ... (Vocus) November 20, 2008 -- Lake Erie Biofuels, LLC , ... biodiesel in the Northeastern United States and will soon be introduced ...
Cached Biology Technology:Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting 2Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting 3Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting 4Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting 5North Carolina's Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs 2North Carolina's Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs 3North Carolina's Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs 4North Carolina's Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs 5Discovery Channel to Feature Lake Erie Biofuels, LLC 2Discovery Channel to Feature Lake Erie Biofuels, LLC 3
(Date:5/11/2015)... N.Y. , May 11, 2015 Curemark ... announced the start of a new Phase III double ... of its novel formulation, CM-AT, on all children ages ... of its FDA Phase III double blinded clinical trial ... had low levels of the digestive enzyme chymotrypsin. This ...
(Date:5/7/2015)... May 7, 2015 Fingerprint ... FPC1022 and FPC1035, FPC,s smallest touch fingerprint sensors ... mainly considered for integration on the backside of ... OEMs increased possibilities to integrate touch fingerprint sensors ... also improves possibilities for module manufacturers to customize ...
(Date:4/27/2015)... 27, 2015  For more than four decades, AUVSI,s ... been the premier worldwide event for the unmanned land, ... must-attend event for any local, national, or trade news ... commercial markets and current applications of unmanned technologies. The ... projected $48 billion industry, and how it will soon ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5
... European Experts in the field of life in extreme ... Antarctic Survey offices in Cambridge (UK) to officially kick ... on life in Extreme Environments). , Life in Extreme ... Europe has considerable expertise but a relatively fragmented research ...
... of the oxygen we breathe today is being produced ... scientists heard today (Wednesday 2 April 2008) at the ... week at the Edinburgh International Conference Centre. About ... photosynthesising creatures called phytoplankton in the major oceans. These ...
... HARBOR, N.Y. (Tuesday, April 1, 2008) Identifying ... in the mouse used to be a monumental task. ... making it effective for even the smallest laboratories. ... ( www.cshprotocols.org/TOCs/toc4_08.dtl ) highlights a method for screening ...
Cached Biology News:Cold Spring Harbor Protocols features methods to screen genomes and analyze evolution 2
Artisan™ Wash Solution (x 50) Additional Information: EU regulatory status: CE US regulatory status: IVD ...
MiniCycler thermal cycler with Hot Bonnet heated lid, holds 25x0.2ml tubes...
... RNA stain is used to stain and ... agarose gels and does not interfere with ... nm transilluminator, the stain emits a red-orange ... film or with a CCD camera-based gel ...
... mitochondrial transmembrane potential is one ... that occur following induction of ... Kit utilizes a lipophilic cation, ... mitochondrial activity marker. MitoLight partitions ...
Biology Products: